Skip to content

Development of a growth hormone treatment prognostic model for short stature children: a multicenter cohort study of short stature children

Development of a growth hormone treatment prognostic model for short stature children: a multicenter cohort study of short stature children

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088204
Enrollment
Unknown
Registered
2024-08-13
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dwarfism

Interventions

NA:NA

Sponsors

Children's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for short stature; Sign informed consent; Plan to receive GH treatment; Plan to attend a study hospital for treatment; Plan to participate in multiple follow-up visits over 12 months during the course of treatment.

Exclusion criteria

Exclusion criteria: Patients with short stature due to secondary hypothalamic pituitary disease; Patients with short stature due to chronic systemic diseases such as liver and kidney; Patients receiving corticosteroids, thyroid hormones, estrogen and other drugs that affect height; Patients with past or current malignant diseases; The presence of any factors deemed unsuitable for inclusion in the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Growth reaction;

Secondary

MeasureTime frame
Genomic data;Image omics data;Metabolomics data;Environmental exposure omics;

Countries

China

Contacts

Public ContactWei Gu

Children's Hospital of Nanjing Medical University

guwei154@163.com+86 25 8311 7399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026